Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 111, Issue 1, 2003, Pages 68-73

  Pochylski, Tomasz ^a   Kwaśniewska, Anna ^b  

^a Medical Center Oslo   (Norway)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

High grade dysplasia; HPV; K RAS; Point mutation; Squamous cell cervical carcinoma

Indexed keywords

DNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CODON; CONTROLLED STUDY; EXON; FEMALE; GENETIC ANALYSIS; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; UTERUS MYOMA; WART VIRUS;

EID: 0141888073     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00205-7     Document Type: Article

References (23)

1. Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell. 70:1992;523-526.
2. zur Hausen H. The role of papilloma viruses in human cancers. Environ. Carcino. Ecotox. Rev. C18(1):2000;1-14.
3. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689.
4. Bos J.L. The ras gene family and human carcinogenesis. Mutat. Res. 195:1988;255-271.
5. Dokianakis D.N., Papaefthimiou M., Tsiveleka A., Spandidos D.A. High prevalence of HPV 18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears. Oncol. Rep. 6:1999;1327-1331.
6. Falcinelli C., Luzi P., Alberti P., Cosmi E.V., Anceschi M.M. Human papilloma virus infection and K-ras oncogene in paraffin-embedded squamous carcinomas of the cervix. Gynecol. Obstet. Invest. 36:1993;185-188.
7. Iwasaka T., Yokoyama M., Oh-Uchida M., Matsuo N., Hara K., Fukuyama K.et al. Detection of human papilloma virus genome and analysis of expression of c-myc and Ha-ras oncogenes in ivasive cervical carcinomas. Gynecol. Oncol. 46:1992;298-303.
8. Burghardt E., Ostor A.G. Site and origin of squamous cervical cancer: a histomorphologic study. Obstet. Gynecol. 174:1983;679-689.
9. Richardt R.M. A modified terminology for cervical intraepithelial neoplasia. Obstet. Gynecol. 75:1990;131-133.
10. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. WHO international classification of tumors: histological typing of female genital tract tumors. Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest: Springer; 1996.
11. Creasman W.T. Announcement, FIGO stages, 1988 revision. Gynecol. Oncol. 35:1989;125-127.
12. Sarkar F.H., Li Y.W., Crissman J.D. A method for PCR sequencing of the p53 gene from a single 10. μm frozen or paraffin-embedded tissue section Biol. Technol. 15:1993;36-38.
13. Olsen A.O., Gjoen K., Sauer T., Ostersavik I., Naess O., Kierulf K. Human papilloma virus and cervical intraepitehelial neoplasia grade II-III: a population based case-control study. Am. J. Epidemiol. 140:1994;700-710.
14. Ranst M, van Tachezy R, Rau HL, Wang LY, Herbrt V. Human papilloma viruses: a neverending story? W: Papilloma virus Revies: Current Research of Papilloma viruses. red. Ch. Lasey, Leeds University Press; 1996. p. 1-19.
15. O'Leary J.J., Landers R.J., Silva I., Uhlmann V., Crowley M., Healy I.et al. Molecular analysis of RAS oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix. J. Clin. Pathol. 51:1998;576-582.
16. Willis G., Jennings B., Ball R.Y., New N.E., Gibson I. Analysis of RAS point mutations and human papilloma virus 16 and 18 in cervical carcinomata and their metastases. Gynecol. Oncol. 49:1993;359-364.
17. Koffa M., Koumantakis E., Ergazaki M., Malamou-Mitsi V., Spandidos D.A. Detection of ras gene mutations and HPV in lesions of the human female reproductive tract. Int. J. Oncol. 5:1994;189-195.
18. Riou G., Barrois M., Sheng Z.M., Duvillard P., Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene. 3:1988;329-333.
19. Utrera-Barillas D., Salcedo-Vargas M., Gargilio-Vidal P., Hernandes-Hernandez D.M., Gutierrez-Delgado F., Benitez-Bribiesca L. H-ras and Nm 23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix. Arch. Med. Res. 31:2000;172-181.
20. Prokopakis P., Sourvinos G., Koumantaki Y., Koumantakis E., Spandiados D.A. K-ras mutation and HPV infection in cervicitis and intraepitehelial neoplasos of the cervix. Oncol. Rep. 9:2002;129-133.
21. Wong Y.F., Chung T.K., Cheung T.H., Xu Y.G., Chang A.M. Frequent ras gene mutations in squamous cell cervical career. Cancer Lett. 95:1995;29-32.
22. Grendys E.C. Jr., Bames W.A., Weitzel J., Sparkowski J., Schlegel R. Identification of H, K, and N-my point mutations in stage IB cervical carcinoma. Gynecol. Oncol. 65:1997;343-347.
23. Stenzel A., Semczuk A., Rozynska K., Jakowicki J., Wojcierowki J. "Low risk" and "high risk" HPV - infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Pathol. Res. Pract. 197:2001;597-603.